LRRC8D
geneOn this page
Also known as FLJ10470
Summary
LRRC8D (leucine rich repeat containing 8 VRAC subunit D, HGNC:16992) is a protein-coding gene on chromosome 1p22.2, encoding Volume-regulated anion channel subunit LRRC8D (Q7L1W4). Non-essential component of the volume-regulated anion channel (VRAC, also named VSOAC channel), an anion channel required to maintain a constant cell volume in response to extracellular or intracellular osmotic changes.
Enables volume-sensitive anion channel activity. Involved in several processes, including monoatomic anion transmembrane transport; organic acid transmembrane transport; and protein hexamerization. Located in cytoplasm and plasma membrane. Part of monoatomic ion channel complex.
Source: NCBI Gene 55144 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 73 total
- MANE Select transcript:
NM_001134479
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16992 |
| Approved symbol | LRRC8D |
| Name | leucine rich repeat containing 8 VRAC subunit D |
| Location | 1p22.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ10470 |
| Ensembl gene | ENSG00000171492 |
| Ensembl biotype | protein_coding |
| OMIM | 612890 |
| Entrez | 55144 |
Gene structure
Transcript identifiers
Ensembl transcripts: 37 — 37 protein_coding
ENST00000337338, ENST00000394593, ENST00000414841, ENST00000441269, ENST00000525774, ENST00000527156, ENST00000532201, ENST00000906496, ENST00000906497, ENST00000906498, ENST00000906499, ENST00000906500, ENST00000906501, ENST00000906502, ENST00000906503, ENST00000906504, ENST00000906505, ENST00000906506, ENST00000906507, ENST00000906508, ENST00000906509, ENST00000906510, ENST00000906512, ENST00000906513, ENST00000906514, ENST00000906516, ENST00000906518, ENST00000906519, ENST00000906520, ENST00000906521, ENST00000932575, ENST00000932576, ENST00000932577, ENST00000947385, ENST00000947386, ENST00000947387, ENST00000947388
RefSeq mRNA: 2 — MANE Select: NM_001134479
NM_001134479, NM_018103
CCDS: CCDS726
Canonical transcript exons
ENST00000337338 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001211945 | 89821032 | 89821291 |
| ENSE00001601130 | 89933067 | 89936611 |
| ENSE00003636666 | 89843638 | 89843782 |
Expression profiles
Bgee: expression breadth ubiquitous, 285 present calls, max score 98.06.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 23.6751 / max 325.6449, expressed in 1815 samples.
FANTOM5 promoters (11 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 3979 | 15.7869 | 1700 |
| 3987 | 3.7849 | 1309 |
| 3978 | 2.3325 | 1127 |
| 3988 | 0.8485 | 507 |
| 3983 | 0.3238 | 143 |
| 3982 | 0.2587 | 132 |
| 3985 | 0.1041 | 54 |
| 3980 | 0.0978 | 26 |
| 3984 | 0.0698 | 33 |
| 3981 | 0.0478 | 11 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| inferior vagus X ganglion | UBERON:0005363 | 98.06 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 97.84 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 97.18 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 97.06 | gold quality |
| medulla oblongata | UBERON:0001896 | 97.04 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 96.94 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 96.81 | gold quality |
| corpus callosum | UBERON:0002336 | 96.76 | gold quality |
| ventral tegmental area | UBERON:0002691 | 96.75 | gold quality |
| gingival epithelium | UBERON:0001949 | 96.51 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 96.37 | gold quality |
| inferior olivary complex | UBERON:0002127 | 96.26 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 96.18 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 96.08 | gold quality |
| pons | UBERON:0000988 | 96.06 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 95.74 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 95.65 | gold quality |
| secondary oocyte | CL:0000655 | 95.11 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 94.87 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 94.81 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 94.79 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 94.65 | gold quality |
| olfactory bulb | UBERON:0002264 | 94.49 | gold quality |
| gingiva | UBERON:0001828 | 94.48 | gold quality |
| dorsal motor nucleus of vagus nerve | UBERON:0002870 | 94.39 | gold quality |
| jejunal mucosa | UBERON:0000399 | 94.32 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 94.15 | gold quality |
| monocyte | CL:0000576 | 94.11 | gold quality |
| mononuclear cell | CL:0000842 | 94.10 | gold quality |
| leukocyte | CL:0000738 | 93.87 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.72 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
68 targeting LRRC8D, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-8062 | 99.88 | 68.43 | 995 |
| HSA-MIR-4503 | 99.85 | 71.45 | 1869 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
Literature-anchored findings (GeneRIF, showing 3)
- identified four genes, named TA-LRRP, AD158, LRRC5, and FLJ23420, as unknown LRRC8-like genes (PMID:15094057)
- LRRC8D is a target gene of the BACH1 transcription factor according to ChIP-seq analysis in HEK 293 cells. (PMID:21555518)
- Cryo-EM structure of the volume-regulated anion channel LRRC8D isoform identifies features important for substrate permeation. (PMID:32415200)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | lrrc8db | ENSDARG00000103840 |
| mus_musculus | Lrrc8d | ENSMUSG00000046079 |
| rattus_norvegicus | Lrrc8d | ENSRNOG00000002121 |
Paralogs (31): LRRC7 (ENSG00000033122), PHLPP2 (ENSG00000040199), LRRC40 (ENSG00000066557), LRCH4 (ENSG00000077454), PHLPP1 (ENSG00000081913), SHOC2 (ENSG00000108061), ERBIN (ENSG00000112851), LRRC39 (ENSG00000122477), LRCH2 (ENSG00000130224), LRCH1 (ENSG00000136141), LRRC8A (ENSG00000136802), LRRC1 (ENSG00000137269), MFHAS1 (ENSG00000147324), LRRC27 (ENSG00000148814), LRRK1 (ENSG00000154237), LRRC58 (ENSG00000163428), LRRC2 (ENSG00000163827), LRRC18 (ENSG00000165383), LRRC28 (ENSG00000168904), LRRC8E (ENSG00000171017), LRRC8C (ENSG00000171488), PIDD1 (ENSG00000177595), SCRIB (ENSG00000180900), LRCH3 (ENSG00000186001), LRRIQ4 (ENSG00000188306), LRRC8B (ENSG00000197147), LRRC10 (ENSG00000198812), LRRC10B (ENSG00000204950), LRRC30 (ENSG00000206422), LRRC69 (ENSG00000214954), LRRD1 (ENSG00000240720)
Protein
Protein identifiers
Volume-regulated anion channel subunit LRRC8D — Q7L1W4 (reviewed: Q7L1W4)
Alternative names: Leucine-rich repeat-containing protein 5, Leucine-rich repeat-containing protein 8D
All UniProt accessions (6): Q7L1W4, E9PJ89, E9PJS7, E9PL08, E9PMF9, Q5VWA0
UniProt curated annotations — full annotation on UniProt →
Function. Non-essential component of the volume-regulated anion channel (VRAC, also named VSOAC channel), an anion channel required to maintain a constant cell volume in response to extracellular or intracellular osmotic changes. The VRAC channel conducts iodide better than chloride and can also conduct organic osmolytes like taurine. Plays a redundant role in the efflux of amino acids, such as aspartate, in response to osmotic stress. LRRC8A and LRRC8D are required for the uptake of the drug cisplatin. Channel activity requires LRRC8A plus at least one other family member (LRRC8B, LRRC8C, LRRC8D or LRRC8E); channel characteristics depend on the precise subunit composition. Also acts as a regulator of glucose-sensing in pancreatic beta cells: VRAC currents, generated in response to hypotonicity- or glucose-induced beta cell swelling, depolarize cells, thereby causing electrical excitation, leading to increase glucose sensitivity and insulin secretion. VRAC channels containing LRRC8D inhibit transport of immunoreactive cyclic dinucleotide GMP-AMP (2’-3’-cGAMP), an immune messenger produced in response to DNA virus in the cytosol. Mediates the import of the antibiotic blasticidin-S into the cell.
Subunit / interactions. Heterohexamer; oligomerizes with other LRRC8 proteins (LRRC8A, LRRC8B, LRRC8C and/or LRRC8E) to form a heterohexamer. In vivo, the subunit composition may depend primarily on expression levels, and heterooligomeric channels containing various proportions of the different LRRC8 proteins may coexist.
Subcellular location. Cell membrane. Endoplasmic reticulum membrane.
Domain organisation. The volume-regulated anion channel (VRAC) channel forms a trimer of dimers, with symmetry mismatch between the pore-forming domain and the cytosolic LRR repeats, a topology similar to gap junction proteins.
Similarity. Belongs to the LRRC8 family.
RefSeq proteins (2): NP_001127951, NP_060573 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001611 | Leu-rich_rpt | Repeat |
| IPR003591 | Leu-rich_rpt_typical-subtyp | Repeat |
| IPR021040 | LRRC8_Pannexin-like | Domain |
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
| IPR050216 | LRR_domain-containing | Family |
Pfam: PF12534, PF13855
Catalyzed reactions (Rhea), 3 shown:
- chloride(in) = chloride(out) (RHEA:29823)
- iodide(out) = iodide(in) (RHEA:66324)
- taurine(out) = taurine(in) (RHEA:66328)
UniProt features (32 total): repeat 13, topological domain 5, transmembrane region 4, modified residue 3, mutagenesis site 2, chain 1, region of interest 1, compositionally biased region 1, disulfide bond 1, sequence variant 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6M04 | ELECTRON MICROSCOPY | 4.36 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7L1W4-F1 | 81.50 | 0.54 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 241, 242, 246
Disulfide bonds (1): 54–354
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 44 | alters channel anion selectivity. |
| 143 | affects ion selectivity of the channel. reduced permeability to negatively charged glutamate and gluconate. |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-5223345 | Miscellaneous transport and binding events |
| R-HSA-382551 | Transport of small molecules |
MSigDB gene sets: 232 (showing top):
GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP, RNGTGGGC_UNKNOWN, TTTGTAG_MIR520D, AREB6_03, GOBP_AMINO_ACID_TRANSMEMBRANE_TRANSPORT, GOBP_NUCLEOTIDE_TRANSPORT, GOBP_ORGANIC_ACID_TRANSPORT, GOBP_ORGANOPHOSPHATE_ESTER_TRANSPORT, GOBP_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORT, GOBP_AMINO_ACID_TRANSPORT, GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT, GOBP_ORGANIC_ANION_TRANSPORT, GOBP_SULFUR_COMPOUND_TRANSPORT, AAAGGGA_MIR204_MIR211, GOBP_DICARBOXYLIC_ACID_TRANSPORT
GO Biological Process (8): intracellular glucose homeostasis (GO:0001678), taurine transmembrane transport (GO:0015734), aspartate transmembrane transport (GO:0015810), protein hexamerization (GO:0034214), cellular response to osmotic stress (GO:0071470), monoatomic anion transmembrane transport (GO:0098656), monoatomic ion transport (GO:0006811), monoatomic ion transmembrane transport (GO:0034220)
GO Molecular Function (2): volume-sensitive anion channel activity (GO:0005225), protein binding (GO:0005515)
GO Cellular Component (6): cytoplasm (GO:0005737), endoplasmic reticulum membrane (GO:0005789), plasma membrane (GO:0005886), membrane (GO:0016020), monoatomic ion channel complex (GO:0034702), endoplasmic reticulum (GO:0005783)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Transport of small molecules | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| nitrogen compound transport | 2 |
| cellular anatomical structure | 2 |
| glucose homeostasis | 1 |
| intracellular chemical homeostasis | 1 |
| alkanesulfonate transmembrane transport | 1 |
| amino acid transmembrane transport | 1 |
| C4-dicarboxylate transport | 1 |
| acidic amino acid transport | 1 |
| carboxylic acid transmembrane transport | 1 |
| protein complex oligomerization | 1 |
| response to osmotic stress | 1 |
| cellular response to chemical stress | 1 |
| cellular response to abiotic stimulus | 1 |
| monoatomic anion transport | 1 |
| monoatomic ion transmembrane transport | 1 |
| transport | 1 |
| monoatomic ion transport | 1 |
| transmembrane transport | 1 |
| monoatomic anion channel activity | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| membrane | 1 |
| cell periphery | 1 |
| transmembrane transporter complex | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1048 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LRRC8D | PCSK4 | Q6UW60 | 629 |
| LRRC8D | TTYH2 | Q9BSA4 | 575 |
| LRRC8D | BEST1 | O76090 | 552 |
| LRRC8D | CLCN3 | P51790 | 547 |
| LRRC8D | CTSW | P56202 | 513 |
| LRRC8D | KCP | Q6ZWJ8 | 510 |
| LRRC8D | TTYH3 | Q9C0H2 | 502 |
| LRRC8D | TTYH1 | Q9H313 | 494 |
| LRRC8D | IHH | Q14623 | 473 |
| LRRC8D | TNFRSF18 | Q9Y5U5 | 469 |
| LRRC8D | CFTR | P13569 | 451 |
| LRRC8D | HEPACAM | Q14CZ8 | 447 |
| LRRC8D | CLCA4 | Q14CN2 | 447 |
| LRRC8D | CLCA2 | Q9UQC9 | 446 |
| LRRC8D | ANO1 | Q5XXA6 | 436 |
IntAct
31 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LRRC8B | SLC25A17 | psi-mi:“MI:0914”(association) | 0.530 |
| LRRC8D | LRRC8D | psi-mi:“MI:0915”(physical association) | 0.490 |
| LRRC8A | LRRC8D | psi-mi:“MI:0915”(physical association) | 0.400 |
| SLC17A2 | PSMD11 | psi-mi:“MI:0914”(association) | 0.350 |
| HTR3A | GPAA1 | psi-mi:“MI:0914”(association) | 0.350 |
| NS3 | C15orf61 | psi-mi:“MI:0914”(association) | 0.350 |
| NBAS | psi-mi:“MI:0914”(association) | 0.350 | |
| SHTN1 | psi-mi:“MI:0914”(association) | 0.350 | |
| TMEM223 | psi-mi:“MI:0914”(association) | 0.350 | |
| SHANK3 | IGKV3D-15 | psi-mi:“MI:0914”(association) | 0.350 |
| SHANK3 | ELAVL2 | psi-mi:“MI:0914”(association) | 0.350 |
| TTYH1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| CHRNA4 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| HCST | TMEM120B | psi-mi:“MI:0914”(association) | 0.350 |
| SIDT2 | KLRG2 | psi-mi:“MI:0914”(association) | 0.350 |
| RXFP1 | UPK3BL1 | psi-mi:“MI:0914”(association) | 0.350 |
| NKAIN1 | GPR89A | psi-mi:“MI:0914”(association) | 0.350 |
| SLC17A2 | ABCD4 | psi-mi:“MI:0914”(association) | 0.350 |
| OR10H2 | ABCD4 | psi-mi:“MI:0914”(association) | 0.350 |
| HTR3A | EXTL3 | psi-mi:“MI:0914”(association) | 0.350 |
| NPEPPS | KIF5B | psi-mi:“MI:0914”(association) | 0.350 |
| OR2H2 | SERPINB8 | psi-mi:“MI:0914”(association) | 0.350 |
| LRRC8B | CDH2 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC22A14 | CLGN | psi-mi:“MI:0914”(association) | 0.350 |
| SLC44A1 | UPK3BL1 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC44A5 | UPK3BL1 | psi-mi:“MI:0914”(association) | 0.350 |
| EXOSC4 | LRRC8D | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (60): LRRC8D (Reconstituted Complex), LRRC8D (Affinity Capture-MS), LRRC8D (Affinity Capture-MS), LRRC8D (Affinity Capture-MS), LRRC8D (Affinity Capture-RNA), LRRC8D (Affinity Capture-RNA), LRRC8D (Affinity Capture-MS), LRRC8D (Proximity Label-MS), LRRC8D (Proximity Label-MS), LRRC8D (Affinity Capture-MS), LRRC8D (Affinity Capture-MS), LRRC8D (Proximity Label-MS), LRRC8D (Proximity Label-MS), LRRC8D (Proximity Label-MS), LRRC8D (Proximity Label-MS)
ESM2 similar proteins: A0JPH4, A2AHL1, A8DZH4, D3ZWZ9, E7FFT2, F1QFU0, F1QZE9, P48763, P50482, P86044, Q28CV2, Q32NZ6, Q3TPR7, Q3ZAS0, Q4R7U0, Q4V8U5, Q5F3F5, Q5M7W4, Q5RH73, Q5YCC5, Q5ZKN3, Q68DH5, Q6GQE1, Q6P4P2, Q6UXY8, Q7L1W4, Q7Z2W7, Q7Z402, Q7ZYA0, Q810F5, Q8BH79, Q8C428, Q8C561, Q8CB19, Q8IZK6, Q8N3S3, Q8R455, Q8R4D5, Q8R4P4, Q8R4P5
Diamond homologs: A5PK13, Q3KRC6, Q498T9, Q4V8I7, Q5DU41, Q5U308, Q66JT1, Q68F79, Q6NSJ5, Q6NU09, Q6P9F7, Q7L1W4, Q80WG5, Q8BGR2, Q8IWT6, Q8R502, Q8TDW0, A6NIV6, Q9Z1S7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
73 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 68 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1483 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:89933066:GGAAT:G | acceptor_gain | 1.0000 |
| 1:89846515:A:AG | acceptor_gain | 0.9900 |
| 1:89846516:G:GG | acceptor_gain | 0.9900 |
| 1:89933061:TTCTA:T | acceptor_loss | 0.9900 |
| 1:89933062:TCTA:T | acceptor_loss | 0.9900 |
| 1:89933062:TCTAG:T | acceptor_loss | 0.9900 |
| 1:89933063:CTAG:C | acceptor_loss | 0.9900 |
| 1:89933063:CTAGG:C | acceptor_loss | 0.9900 |
| 1:89933064:TA:T | acceptor_loss | 0.9900 |
| 1:89933064:TAGG:T | acceptor_loss | 0.9900 |
| 1:89933065:A:AG | acceptor_gain | 0.9900 |
| 1:89933065:AG:A | acceptor_gain | 0.9900 |
| 1:89933065:AGG:A | acceptor_loss | 0.9900 |
| 1:89933065:AGGA:A | acceptor_loss | 0.9900 |
| 1:89933066:G:A | acceptor_loss | 0.9900 |
| 1:89933066:G:C | acceptor_loss | 0.9900 |
| 1:89933066:G:GG | acceptor_gain | 0.9900 |
| 1:89933066:GG:G | acceptor_gain | 0.9900 |
| 1:89933066:GGA:G | acceptor_gain | 0.9900 |
| 1:89846515:AGTCT:A | acceptor_gain | 0.9800 |
| 1:89846516:GTCTG:G | acceptor_gain | 0.9800 |
| 1:89895391:C:G | donor_gain | 0.9800 |
| 1:89933066:GGAA:G | acceptor_gain | 0.9800 |
| 1:89821288:CAAG:C | donor_loss | 0.9700 |
| 1:89821289:AAG:A | donor_loss | 0.9700 |
| 1:89821290:AG:A | donor_loss | 0.9700 |
| 1:89821291:GG:G | donor_loss | 0.9700 |
| 1:89821292:G:GC | donor_loss | 0.9700 |
| 1:89821293:T:G | donor_loss | 0.9700 |
| 1:89846516:GTCT:G | acceptor_gain | 0.9700 |
AlphaMissense
5730 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:89933138:T:A | W24R | 1.000 |
| 1:89933138:T:C | W24R | 1.000 |
| 1:89933228:T:C | C54R | 1.000 |
| 1:89933230:T:G | C54W | 1.000 |
| 1:89933527:T:G | C153W | 1.000 |
| 1:89933690:T:A | W208R | 1.000 |
| 1:89933690:T:C | W208R | 1.000 |
| 1:89933692:G:C | W208C | 1.000 |
| 1:89933692:G:T | W208C | 1.000 |
| 1:89934128:T:A | C354S | 1.000 |
| 1:89934128:T:C | C354R | 1.000 |
| 1:89934129:G:C | C354S | 1.000 |
| 1:89934130:C:G | C354W | 1.000 |
| 1:89934377:T:C | F437L | 1.000 |
| 1:89934379:C:A | F437L | 1.000 |
| 1:89934379:C:G | F437L | 1.000 |
| 1:89934405:T:C | L446P | 1.000 |
| 1:89934731:T:A | W555R | 1.000 |
| 1:89934731:T:C | W555R | 1.000 |
| 1:89933140:G:C | W24C | 0.999 |
| 1:89933140:G:T | W24C | 0.999 |
| 1:89933228:T:A | C54S | 0.999 |
| 1:89933229:G:A | C54Y | 0.999 |
| 1:89933229:G:C | C54S | 0.999 |
| 1:89933525:T:A | C153S | 0.999 |
| 1:89933525:T:C | C153R | 0.999 |
| 1:89933526:G:A | C153Y | 0.999 |
| 1:89933526:G:C | C153S | 0.999 |
| 1:89933526:G:T | C153F | 0.999 |
| 1:89933615:T:A | W183R | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000025483 (1:89821379 C>G), RS1000037636 (1:89864004 A>G), RS1000053139 (1:89877600 G>A), RS1000056223 (1:89906691 A>G), RS1000056682 (1:89821482 T>G), RS1000061123 (1:89841439 C>T), RS1000140670 (1:89890333 C>G), RS1000142680 (1:89928394 A>G), RS1000151720 (1:89855914 A>C), RS1000167531 (1:89846051 T>G), RS1000274733 (1:89921695 C>T), RS1000309603 (1:89883452 T>C), RS1000319902 (1:89840153 G>A), RS1000409975 (1:89846631 T>G), RS1000427376 (1:89919497 A>G)
Disease associations
OMIM: gene MIM:612890 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002774_1 | Cognitive function | 3.000000e-06 |
| GCST003434_11 | Obsessive-compulsive symptoms | 8.000000e-06 |
| GCST004748_70 | Lung cancer | 4.000000e-06 |
| GCST004750_98 | Squamous cell lung carcinoma | 1.000000e-06 |
| GCST006210_1 | Thiopurine-induced digestive symptoms in inflammatory bowel disease | 7.000000e-07 |
| GCST90002395_312 | Mean platelet volume | 6.000000e-12 |
| GCST90002395_313 | Mean platelet volume | 4.000000e-13 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004337 | intelligence |
| EFO:0007802 | obsessive-compulsive symptom measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
50 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | decreases expression, decreases methylation, increases expression | 3 |
| bisphenol A | affects cotreatment, decreases methylation, decreases expression | 2 |
| sodium arsenite | decreases expression, increases expression | 2 |
| Estradiol | decreases expression, affects cotreatment | 2 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 2 |
| Cyclosporine | increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | increases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| pirinixic acid | decreases expression, increases activity, affects binding | 1 |
| cobaltous chloride | decreases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| resorcinol | decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| avobenzone | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| monomethylarsonous acid | decreases expression | 1 |
| abrine | decreases expression | 1 |
| prothioconazole | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Leflunomide | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Vehicle Emissions | decreases methylation | 1 |
Cellosaurus cell lines
4 cell lines: 4 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_SV96 | HAP1 LRRC8D (-) 1 | Cancer cell line | Male |
| CVCL_SV97 | HAP1 LRRC8D (-) 2 | Cancer cell line | Male |
| CVCL_SV98 | HAP1 LRRC8D (-) 3 | Cancer cell line | Male |
| CVCL_SV99 | HAP1 LRRC8D (-) 4 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): digestive system disorder, squamous cell lung carcinoma